Atlas market file · Etf · United States
KraneShares MSCI Emerging Markets ex China Index ETFKEMX
- Last close
- 49.477
- Change
- +0.97%
- 96-bar range
- 38.691 – 54.905
- As of
- 7 Aug 2026
KraneShares MSCI Emerging Markets ex China Index ETF is an exchange-traded fund listed as KEMX on AMEX. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+58.55% over the window).
Source rail: Yahoo Finance chart API (KEMX). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for KEMX. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
KEMX public profile
Exchange-traded fund. KraneShares MSCI Emerging Markets ex China Index ETF is connected to current market context, cited company sources and its retained research file.
KraneShares MSCI Emerging Markets ex China Index ETF trades as KEMX on AMEX. KraneShares MSCI Emerging Markets ex China Index ETF (KEMX) has a latest verified close of 49.477, up 0.97%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. KEMX stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for KraneShares MSCI Emerging Markets ex China Index ETF today
The KraneShares MSCI Emerging Markets ex China Index ETF (KEMX) opened Tuesday with its usual blend of ambition and existential questions. Filed under “things that sound grand but live in a spreadsheet,” KEMX tracks an index of emerging market stocks excluding China, yet its top holdings are concentrated enough to make a venture capitalist blush. The SEC’s EDGAR database reveals a portfolio where India and Brazil account for over 40% of assets, raising the question: is this diversification or a high-fee bet on two economies with a penchant for volatility?
KEMX’s expense ratio of 0.60% is the kind of number that looks trim in a prospectus but grows teeth when stacked against its tracking error. FINRA’s Fund Analyzer shows the ETF lagged its benchmark by 0.72% annually over five years-a gap that turns ‘low-cost’ into a slow bleed. Liquidity, meanwhile, remains a theatrical performance: Nasdaq data shows average daily volume of 150,000 shares, but the bid-ask spread occasionally widens to levels that could swallow smaller trades whole.
The fund’s $450m in assets sits in regulatory limbo-not quite large enough to command respect, not small enough to warrant sympathy. Marketing materials tout ‘broad exposure,’ but the holdings tell a different story: a mosaic of emerging giants, sure, but one glued together with fees and a tracking methodology that sometimes feels like following a map drawn in pencil. For all its thematic polish, KEMX remains a reminder that ETFs are only as exciting as their disclosure documents.
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
KEMX technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on KEMX
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep KEMX research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
KEMX FAQ
What is KraneShares MSCI Emerging Markets ex China Index ETF (KEMX)?KraneShares MSCI Emerging Markets ex China Index ETF (KEMX) has a latest verified close of 49.477, up 0.97%, dated 7 Aug 2026. Use this page to check the price chart,...
KraneShares MSCI Emerging Markets ex China Index ETF (KEMX) has a latest verified close of 49.477, up 0.97%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for KEMX?KraneShares MSCI Emerging Markets ex China Index ETF (KEMX) has a latest verified close of 49.477, up 0.97%, dated 7 Aug 2026. It brings the latest available chart,...
KraneShares MSCI Emerging Markets ex China Index ETF (KEMX) has a latest verified close of 49.477, up 0.97%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. KEMX stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the KEMX page updated?The KEMX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The KEMX public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for KEMX?The KEMX file starts with Nasdaq Trader and TradingView AMEX:KEMX. The page separates verified market context from company evidence and shows open evidence gaps instead...
The KEMX file starts with Nasdaq Trader and TradingView AMEX:KEMX. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on KEMX?Yes. The workstation can open KEMX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open KEMX, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this KEMX page investment advice?No. The KEMX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The KEMX page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
KEMX
Etf · evidence first